＜2024年 業績論文＞

・Ryo Suzuki, Hanan Amadid, Atheline Major-Pedersen, Daisuke Yabe. PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan. J Diabetes Investig. 2024 May 6; doi: 10.1111/jdi.14219.

・Ryo Suzuki, Kiyoyasu Kazumori, Tatsuya Usui, Masahiko Shinohara. Medical database analysis of the association between kidney function and achievement of glycemic control in older Japanese adults with type 2 diabetes who started with oral antidiabetic drugs. J Diabetes Investig. 2024 April 18; doi: 10.1111/jdi.14214.

・Keiji Sugai, Takashi Miwa, Junya Kojima, Yuri Ueda, Kiyoaki Tsukahara, Hirotaka Nishi, Ryo Suzuki. Pregnancy and delivery in an advanced cancer survivor with immune checkpoint inhibitor-induced type 1 diabetes: a case report. Endocrine. 2024 Mar 19; doi: 10.1007/s12020-024-03780-w.

・Hye M. Hwang, Satoshi Yamashita, Yu Matsumoto, Mariko Ito, Alex Edwards, Junko Sasaki, Dipankar J. Dutta, Shahid Mohammad, Chiho Yamashhita, Leah Wetherill, Tae-Hwi Schwanters-An, Marco Abreu, Amanda H. Mattson, Tatiana Foroud, Rajesh C. Miranda, Christina Chambers, Masaaki Torii, Kazue Hashimoto-Torii. Reduction of APOE accounts for neurobehavioral deficits in fetal alcohol spectrum disorders. Mol Psychiatry. 2024 May 11; doi: 10.1038/s41380-024-02586-6.

･ Keiji Sugai, Junko Sasaki, Yuki Wada, Norihiro Shimizu, Takuya Ishikawa, Ketchu Yanagi, Takeshi Hashimoto, Akihiko Tanaka, Hirotsugu Suwanai, Ryo Suzuki, Masato Odawara. Predictive patterns of lower urinary tract symptoms and bacteriuria in adults with type 2 diabetes. Diabetol Int. 2024 Jan 23;15(2):253-261. doi: 10.1007/s13340-023-00687-1.

･Keiji Sugai, Takashi Miwa, Junya Kojima, Yuri Ueda, Kiyoaki Tsukahara, Hirotaka Nishi, Ryo Suzuki. Pregnancy and delivery in an advanced cancer survivor with immune checkpoint inhibitor-induced type 1 diabetes: a case report. Endocrine. 2024 Mar 19. doi: 10.1007/s12020-024-03780-w.

･Shumei Kawashima, Hironori Abe, Norihiro Shimizu, Junpei Shikuma, Ryo Suzuki. A Case of Diabetic Ketoacidosis Complicated With Necrotizing Esophagitis. Cureus. 2024 Jan 24;16(1):e52871.

･Hajime Iwasaki, Hirotsugu Suwanai, Fumiyoshi Yakou, Hiroyuki Sakai, Keitaro Ishii, Natsuko Hara, Ashley M Buckle, Kohsuke Kanekura, Tamami Miyagi, Satoshi Narumi, Ryo Suzuki. Disulfide bonds of thyroid peroxidase are critical elements for subcellular localization, proteasome-dependent degradation, and enzyme activity. Thyroid . 2024 Apr 11. doi: 10.1089/thy.2023.0514.

＜2023年 業績論文＞

･ Hara N, Suwanai H, Yakou F, Ishii K, Iwasaki H, Abe H, et al. Clinical characteristics and human leukocyte antigens in patients with immune checkpoint inhibitor-induced type 1 diabetes and pituitary dysfunction: a single center prospective study. Endocrine. 2023;81(3):477-83.

･Sugai K, Shikuma J, Hiroike S, Abe H, Suzuki R. Successful introduction of sensor-augmented pump therapy in a patient with diabetes and needle phobia: A case report. J Diabetes Investig. 2023 Nov;14(11):1318-1320.

･Dipankar J Dutta, Junko Sasaki, Ankush Bansal, Keiji Sugai, Satoshi Yamashita, Guojiao Li, Christopher Lazarski, Li Wang, Toru Sasaki, Chiho Yamashita, Heather Carryl, Ryo Suzuki, Masato Odawara, Yuka Imamura Kawasawa, Pasko Rakic, Masaaki Torii, Kazue Hashimoto-Torii. Proc Natl Acad Sci USA. 2023 Dec 12;120(50):e2304074120. https://doi.org/10.1073/pnas.2304074120

･Yasuhiro Iijima, Masafumi Nakayama, Takashi Miwa, Fumiyoshi Yakou, Hirofumi Tomiyama, Junpei Shikuma, Rokuro Ito, Akihiko Tanaka, Naoki Manda, Masato Odawara. Nephroprotective Effects of Dapagliflozin in Patients with Type 2 Diabetes. Intern Med 62: 681-688, 2023

･Ryotaro Bouchi, Tatsuya Kondo, Yasuharu Ohta, Atsushi Goto, Daisuke Tanaka, Hiroaki Satoh, Daisuke Yabe, Rimei Nishimura, Norio Harada, Hideki Kamiya, Ryo Suzuki, Toshimasa Yamauchi. A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes. Diabetol Int. 2022 Dec 23;14(1):1-14.

･Ryo Suzuki, Kiyoyasu Kazumori, Tatsuya Usui, Masahiko Shinohara. Prevalence and predictors of clinical inertia in patients with type 2 diabetes who were treated with a single oral antidiabetic drug. J Diabetes Investig. 2023 Jan;14(1):81-91.

＜2023年　学会発表＞

第66回日本糖尿病学会年次学術集会

・「糖尿病教育入院の有無で長期的な血糖改善効果に違いがあるかを比較検討する」上坂 朋，他　

・「人工関節術後の血糖変動を予測する因子の検討」　廣池 聡，他

・「糖尿病合併妊娠モデルマウスの仔の大脳における IL-17 関連遺伝子の発現の検討」　菅井 啓自，他

・「1 型糖尿病患者に対する SGLT2 阻害薬の副作用モニタリング」　坂井 千夏，他

・「DPC データを用いた糖尿病の COVID-19 に対する影響の分析」　諏訪内浩紹，他

・「糖尿病患者における COVID-19 ワクチンの有効性の検討」　富澤 学之，他

ADA 83rd Scientific Sessions (第８３回米国糖尿病学会)

・「Interleukin-17 Signaling in Cerebrum of Offspring from Mother with Diabetes」　菅井 啓自 他

第66回日本甲状腺学術集会

・「甲状腺ペルオキシダーゼ活性におけるジスルフィド結合の重要性の検討」　岩崎 源 他

＜2022年 業績論文＞

･Iwasaki H, Suwanai H, Sakai H, Ishii K, Hara N, Satomi K, et al. Ventricular fibrillation immediately after the treatment of Graves' disease coexisting with atypical angina and long QT syndrome: a case report. Thyroid Res. 2022;15(1):18.

･Shikuma J, Nagai Y, Sakurai M, Udagawa K, Ito R, Miwa T, et al. Impact of gender differences on lifestyle and glycemic control in Japanese patients with diabetes during COVID-19 lockdowns. Prim Care Diabetes. 2022;16(3):350-4.

･Shikuma J, Sakakura K, Sugiyama-Takahashi M, Nakamura Y, Nagai Y, Suwanai H, et al. Hematocrit elevation after SGLT2 inhibitor administration may be associated with the degree of proximal tubular damage. Medicine (Baltimore). 2022;101(42):e31122.

･Suzuki R, Kazumori K, Usui T, Shinohara M. Prevalence and predictors of clinical inertia in patients with type?2 diabetes who were treated with a single oral antidiabetic drug. J Diabetes Investig. 2023;14(1):81-91.

･Tamaru S, Suwanai H, Abe H, Sasaki J, Ishii K, Iwasaki H, et al. Machine learning approach to predict subtypes of primary aldosteronism is helpful to estimate indication of adrenal vein sampling. High Blood Press Cardiovasc Prev. 2022;29(4):375-83.

･Ryotaro Bouchi, Tatsuya Kondo, Yasuharu Ohta, Atsushi Goto, Daisuke Tanaka, Hiroaki Satoh, Daisuke Yabe 7, Rimei Nishimura, Norio Harada, Hideki Kamiya, Ryo Suzuki, Toshimasa Yamauchi. A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes.

･Asuka Kato, Kazuhiro Yoshiuchi, Hideki Hashimoto, Ryo Suzuki, Toshimasa Yamauchi, Takashi Kadowaki. Feasibility, acceptability, and effects of a self-stigma reduction pilot program for Japanese individuals with type 2 diabetes. PEC Innov. 2022 Nov 28:2:100112.

･志熊淳平, 伊藤禄郎, 坂倉圭一, 三輪隆, 鈴木亮. GLP-1受容体作動薬の美容・痩身目的での使用と神経性やせ症発症の危険性. 肥満研究 vol28 No.2 2022 レター

･菅井啓自, 鈴木亮. COVID-19と1型糖尿病. 医学のあゆみ 282 (4) 275-279, 2022

･ 赤岡寛晃, 鈴木亮. 超高齢化時代の糖尿病診療4．カテゴリー分類と血糖コントロール目標の考え方. 糖尿病65(9)：487-490，2022

＜2022年　学会発表＞

第65回日本糖尿病学会年次学術集会

・「透析導入前に高血圧性脳症を起こした糖尿病性腎症の症例」石井 智也　等

・「2021年度糖尿病週間における当院の試み 第7回東医ブルーサークルフェスタ」坂井千夏　他

・「インスリンポンプ導入目的の入院中における運動療法の検討 理学療法士を中心とした多職種の介入について」柴崎修平 他

・「人工関節置換術後の患者の血糖管理について」　長谷川大輔　他

・「糖尿病合併妊娠の仔における耐糖能障害と胎内環境および哺育の影響」石井慶太朗　他

・「2型糖尿病患者におけるFib4 indexを用いた肝線維化ハイリスク症状の特徴」高橋摩耶　他

第95回 日本内分泌学会総会

・「免疫チェックポイント阻害薬による下垂体機能低下症発症の予測因子の検討」原菜津子　他

・「ジスルフィド結合結合の消失を伴う甲状腺ペルオキシダーゼ変異の機能と構造解析」岩崎　源　他

82nd scientific sessions American Diabetes Association

・「Exposures To Hyperglycemia In The Embryonic Period And To Breast Milk From Mothers With Hyperglycemia Affect Glucose Tolerance With Higher glucagon-like peptide-1 Secretion」　KEITARO ISHII

＜2021年業績 英語論文＞

･Hara N, Suwanai H, Abe H, Yakou F, Ishikawa T, Urayama M, et al. Hypercalcemia associated with dysgerminoma and elevation of calcitriol: A case report and review of the literature. SAGE Open Med Case Rep. 10. England: c The Author(s) 2022.; 2022. p. 2050313x211068562.

･Ishikawa T, Sakai H, Itaya T, Hirotsugu S, Shikuma J, Miwa T, et al. Falsely diagnosed thyrotoxicosis caused by anti-streptavidin antibodies and pre-wash procedures. Thyroid Res. 2021;14(1):17.

･Odawara M, Aoi S, Takeshima T, Iwasaki K. Comparative Effects of Metformin and Dipeptidyl Peptidase-4 Inhibitors in Japanese Obese Patients with Type 2 Diabetes: A Claims Database Study. Diabetes Ther. 2021;12(8):2165-77.

･Sakurai M, Sasaki J, Suwanai H, Shikuma J, Ito R, Odawara M, et al. A cross-sectional study of the correlation between diabetic therapy and serum zinc concentrations. Diabetol Int. 2022;13(1):177-87.

･Suwanai H, Watanabe R, Matsumura H. Reply: Dipeptidyl Peptidase-4 Inhibitor Reduces the Risk of Developing Hypertrophic Scars and Keloids following Median Sternotomy in Diabetic Patients: A Nationwide Retrospective Cohort Study Using the National Database of Health Insurance Claims of Japan. Plast Reconstr Surg. 147. United States2021. p. 1068e-9e.

･Suzuki R, Saita S, Nishigaki N, Kisanuki K, Shimasaki Y, Mineyama T, et al. Factors Associated With Treatment Adherence and Satisfaction in Type 2 Diabetes Management in Japan: Results From a Web-Based Questionnaire Survey. Diabetes Ther. 2021;12(9):2343-58.

･Yakou F, Saburi M, Hirose A, Akaoka H, Hirota Y, Kobayashi T, et al. A Case Series of Ketoacidosis After Coronavirus Disease 2019 Vaccination in Patients With Type 1 Diabetes. Front Endocrinol (Lausanne). 2022;13:840580.

＜2020年業績 英語論文 共著＞

･Yakou F, Suwanai H, Ishikawa T, Itou M, Shikuma J, Miwa T, et al. A Novel Homozygous Mutation of Thyroid Peroxidase Gene Abolishes a Disulfide Bond Leading to Congenital Hypothyroidism. Int J Endocrinol. 2020;2020:9132372.

･Ishikawa T, Suwanai H, Shikuma J, Suzuki R, Yamanaka T, Odawara M, et al. Protein kinase?C promotes choline transporter?like protein?1 function via improved cell surface expression in immortalized human hepatic cells. Mol Med Rep. 2020;21(2):777-85.

･Suwanai H, Watanabe R, Sato M, Odawara M, Matsumura H. DPP-4 Inhibitor Reduces the Risk of Developing Hypertrophic Scars and Keloids following Median Sternotomy in Diabetic Patients: A nationwide retrospective cohort study using the National Database of Health Insurance Claims of Japan. Plast Reconstr Surg. 2020.

･Hirota Y, Suwanai H, Yamauchi T, Kadowaki T. Clinical Features of Type B Insulin Resistance in Japanese Patients: Case Report and Survey-Based Case Series Study. J Diabetes Res. 2020;2020:4359787.

･Ito Y, Sakai H, Nagao H, Suzuki R, Odawara M, Minato K. Development of a high-performance liquid chromatography-tandem mass spectrometric method for the determination of Methimazole in human blood matrices. J Chromatogr B Analyt Technol Biomed Life Sci. 2020;1144:122083.

･Kato A, Fujimaki Y, Fujimori S, Isogawa A, Onishi Y, Suzuki R, et al. How self-stigma affects patient activation in persons with type 2 diabetes: a cross-sectional study. BMJ Open. 2020;10(5):e034757.

*代表的な論文/発表を抜粋しています。